A clinical performance study to evaluate the utility of QA Commons in patients with advanced solid tumors undergoing comprehensive genomic profiling

QA Commons CGP - QA Commons CGP

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000058128

Enrollment

120

Registered

2025-06-09

Start date

2025-06-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Written informed consent has been obtained for participation in the "Multicenter Clinical Registry Study by Academia Assembly", and the participant has not withdrawn or refused consent. 2. The participant was 18 years of age or older at the time of consent to the "Multicenter Clinical Registry Study by Academia Assembly". 3. The participant has undergone comprehensive genomic profiling (CGP) testing in routine clinical practice.

Exclusion criteria

Exclusion criteria: 1) Required data for this study are missing. 2) The investigator deems the participant to be ineligible.

Design outcomes

Primary

Measure	Time frame
Concordance between treatment recommendations by QA Commons and consensus annotations	—

Secondary

Measure	Time frame
Concordance between treatment recommendations by QA Commons and those made by expert panels at designated core cancer hospitals and other institutions	—

Countries

Japan

Contacts

Public ContactTakao Fujisawa

National Cancer Center Hospital East Division of Drug Development Promotion

qac01-01@yokohama-cu.ac.jp04-7133-1111

Outcome results